 | • レポートコード：MRC2012A8023 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、関節リウマチ治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。関節リウマチ治療薬の種類別市場規模（バイオ医薬品、医薬品）、用途別市場規模（処方箋、店頭（OTC））、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：AbbVie、UCB、Regeneron Pharmaceuticals、Boehringer Ingelheim、Roche、Novartis、Bristol-Myers Squibb Company、Pfizer、Johnson & Johnson、 ・地域別グローバル市場分析 2015年-2020年 ・関節リウマチ治療薬の北米市場（アメリカ、カナダ、メキシコ） ・関節リウマチ治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・関節リウマチ治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・関節リウマチ治療薬の南米市場（ブラジル、アルゼンチン） ・関節リウマチ治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：バイオ医薬品、医薬品 ・用途別分析：処方箋、店頭（OTC） ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Rheumatoid Arthritis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Rheumatoid Arthritis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Rheumatoid Arthritis Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Rheumatoid Arthritis Drug market has been segmented into
Biopharmaceutical
Pharmaceuticals
By Application, Rheumatoid Arthritis Drug has been segmented into:
Prescription
Over-the-Counter (OTC)
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rheumatoid Arthritis Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Rheumatoid Arthritis Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rheumatoid Arthritis Drug market.
The report offers in-depth assessment of the growth and other aspects of the Rheumatoid Arthritis Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Rheumatoid Arthritis Drug Market Share Analysis
Rheumatoid Arthritis Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rheumatoid Arthritis Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rheumatoid Arthritis Drug sales, revenue and market share for each player covered in this report.
The major players covered in Rheumatoid Arthritis Drug are:
AbbVie
UCB
Regeneron Pharmaceuticals
Boehringer Ingelheim
Roche
Novartis
Bristol-Myers Squibb Company
Pfizer
Johnson & Johnson
Among other players domestic and global, Rheumatoid Arthritis Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Rheumatoid Arthritis Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Rheumatoid Arthritis Drug, with price, sales, revenue and global market share of Rheumatoid Arthritis Drug in 2018 and 2019.
Chapter 3, the Rheumatoid Arthritis Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Rheumatoid Arthritis Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Rheumatoid Arthritis Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Rheumatoid Arthritis Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Rheumatoid Arthritis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rheumatoid Arthritis Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Biopharmaceutical
1.2.3 Pharmaceuticals
1.3 Market Analysis by Application
1.3.1 Overview: Global Rheumatoid Arthritis Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Prescription
1.3.3 Over-the-Counter (OTC)
1.4 Overview of Global Rheumatoid Arthritis Drug Market
1.4.1 Global Rheumatoid Arthritis Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AbbVie SWOT Analysis
2.1.4 AbbVie Product and Services
2.1.5 AbbVie Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 UCB
2.2.1 UCB Details
2.2.2 UCB Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 UCB SWOT Analysis
2.2.4 UCB Product and Services
2.2.5 UCB Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Regeneron Pharmaceuticals
2.3.1 Regeneron Pharmaceuticals Details
2.3.2 Regeneron Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Regeneron Pharmaceuticals SWOT Analysis
2.3.4 Regeneron Pharmaceuticals Product and Services
2.3.5 Regeneron Pharmaceuticals Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer Ingelheim SWOT Analysis
2.4.4 Boehringer Ingelheim Product and Services
2.4.5 Boehringer Ingelheim Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Roche SWOT Analysis
2.5.4 Roche Product and Services
2.5.5 Roche Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bristol-Myers Squibb Company
2.7.1 Bristol-Myers Squibb Company Details
2.7.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bristol-Myers Squibb Company SWOT Analysis
2.7.4 Bristol-Myers Squibb Company Product and Services
2.7.5 Bristol-Myers Squibb Company Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Pfizer
2.8.1 Pfizer Details
2.8.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Pfizer SWOT Analysis
2.8.4 Pfizer Product and Services
2.8.5 Pfizer Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Johnson & Johnson
2.9.1 Johnson & Johnson Details
2.9.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Johnson & Johnson SWOT Analysis
2.9.4 Johnson & Johnson Product and Services
2.9.5 Johnson & Johnson Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Rheumatoid Arthritis Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Rheumatoid Arthritis Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Rheumatoid Arthritis Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Rheumatoid Arthritis Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Rheumatoid Arthritis Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Rheumatoid Arthritis Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Rheumatoid Arthritis Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
4.3 Europe Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
4.5 South America Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Rheumatoid Arthritis Drug Sales, Revenue and Market Share by Country
5.1.1 North America Rheumatoid Arthritis Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Rheumatoid Arthritis Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
5.3 Canada Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Rheumatoid Arthritis Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Rheumatoid Arthritis Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Rheumatoid Arthritis Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
6.3 UK Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
6.4 France Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
6.5 Russia Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
6.6 Italy Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Rheumatoid Arthritis Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Rheumatoid Arthritis Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Rheumatoid Arthritis Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
7.3 Japan Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
7.4 Korea Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
7.5 India Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
7.7 Australia Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Rheumatoid Arthritis Drug Sales, Revenue and Market Share by Country
8.1.1 South America Rheumatoid Arthritis Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Rheumatoid Arthritis Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Rheumatoid Arthritis Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Rheumatoid Arthritis Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Rheumatoid Arthritis Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Rheumatoid Arthritis Drug Sales and Market Share by Type (2015-2020)
10.2 Global Rheumatoid Arthritis Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Rheumatoid Arthritis Drug Price by Type (2015-2020)
11 Global Rheumatoid Arthritis Drug Market Segment by Application
11.1 Global Rheumatoid Arthritis Drug Sales Market Share by Application (2015-2020)
11.2 Global Rheumatoid Arthritis Drug Revenue Market Share by Application (2015-2020)
11.3 Global Rheumatoid Arthritis Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Rheumatoid Arthritis Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Rheumatoid Arthritis Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Rheumatoid Arthritis Drug Market Forecast (2021-2025)
12.2.2 Europe Rheumatoid Arthritis Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Rheumatoid Arthritis Drug Market Forecast (2021-2025)
12.2.4 South America Rheumatoid Arthritis Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Rheumatoid Arthritis Drug Market Forecast (2021-2025)
12.3 Rheumatoid Arthritis Drug Market Forecast by Type (2021-2025)
12.3.1 Global Rheumatoid Arthritis Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Rheumatoid Arthritis Drug Market Share Forecast by Type (2021-2025)
12.4 Rheumatoid Arthritis Drug Market Forecast by Application (2021-2025)
12.4.1 Global Rheumatoid Arthritis Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Rheumatoid Arthritis Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Rheumatoid Arthritis Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Rheumatoid Arthritis Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Rheumatoid Arthritis Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AbbVie Basic Information, Manufacturing Base and Competitors
Table 8. AbbVie Rheumatoid Arthritis Drug Major Business
Table 9. AbbVie Rheumatoid Arthritis Drug Total Revenue (USD Million) (2017-2018)
Table 10. AbbVie SWOT Analysis
Table 11. AbbVie Rheumatoid Arthritis Drug Product and Services
Table 12. AbbVie Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. UCB Basic Information, Manufacturing Base and Competitors
Table 14. UCB Rheumatoid Arthritis Drug Major Business
Table 15. UCB Rheumatoid Arthritis Drug Total Revenue (USD Million) (2017-2018)
Table 16. UCB SWOT Analysis
Table 17. UCB Rheumatoid Arthritis Drug Product and Services
Table 18. UCB Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Regeneron Pharmaceuticals Rheumatoid Arthritis Drug Major Business
Table 21. Regeneron Pharmaceuticals Rheumatoid Arthritis Drug Total Revenue (USD Million) (2017-2018)
Table 22. Regeneron Pharmaceuticals SWOT Analysis
Table 23. Regeneron Pharmaceuticals Rheumatoid Arthritis Drug Product and Services
Table 24. Regeneron Pharmaceuticals Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 26. Boehringer Ingelheim Rheumatoid Arthritis Drug Major Business
Table 27. Boehringer Ingelheim Rheumatoid Arthritis Drug Total Revenue (USD Million) (2017-2018)
Table 28. Boehringer Ingelheim SWOT Analysis
Table 29. Boehringer Ingelheim Rheumatoid Arthritis Drug Product and Services
Table 30. Boehringer Ingelheim Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Roche Basic Information, Manufacturing Base and Competitors
Table 32. Roche Rheumatoid Arthritis Drug Major Business
Table 33. Roche Rheumatoid Arthritis Drug Total Revenue (USD Million) (2017-2018)
Table 34. Roche SWOT Analysis
Table 35. Roche Rheumatoid Arthritis Drug Product and Services
Table 36. Roche Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis Basic Information, Manufacturing Base and Competitors
Table 38. Novartis Rheumatoid Arthritis Drug Major Business
Table 39. Novartis Rheumatoid Arthritis Drug Total Revenue (USD Million) (2017-2018)
Table 40. Novartis SWOT Analysis
Table 41. Novartis Rheumatoid Arthritis Drug Product and Services
Table 42. Novartis Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 44. Bristol-Myers Squibb Company Rheumatoid Arthritis Drug Major Business
Table 45. Bristol-Myers Squibb Company Rheumatoid Arthritis Drug Total Revenue (USD Million) (2017-2018)
Table 46. Bristol-Myers Squibb Company SWOT Analysis
Table 47. Bristol-Myers Squibb Company Rheumatoid Arthritis Drug Product and Services
Table 48. Bristol-Myers Squibb Company Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Pfizer Basic Information, Manufacturing Base and Competitors
Table 50. Pfizer Rheumatoid Arthritis Drug Major Business
Table 51. Pfizer Rheumatoid Arthritis Drug Total Revenue (USD Million) (2017-2018)
Table 52. Pfizer SWOT Analysis
Table 53. Pfizer Rheumatoid Arthritis Drug Product and Services
Table 54. Pfizer Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 56. Johnson & Johnson Rheumatoid Arthritis Drug Major Business
Table 57. Johnson & Johnson Rheumatoid Arthritis Drug Total Revenue (USD Million) (2017-2018)
Table 58. Johnson & Johnson SWOT Analysis
Table 59. Johnson & Johnson Rheumatoid Arthritis Drug Product and Services
Table 60. Johnson & Johnson Rheumatoid Arthritis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Global Rheumatoid Arthritis Drug Sales by Manufacturer (2018-2019) (K Units)
Table 62. Global Rheumatoid Arthritis Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 63. Global Rheumatoid Arthritis Drug Sales by Regions (2015-2020) (K Units)
Table 64. Global Rheumatoid Arthritis Drug Sales Market Share by Regions (2015-2020)
Table 65. Global Rheumatoid Arthritis Drug Revenue by Regions (2015-2020) (USD Million)
Table 66. North America Rheumatoid Arthritis Drug Sales by Countries (2015-2020) (K Units)
Table 67. North America Rheumatoid Arthritis Drug Sales Market Share by Countries (2015-2020)
Table 68. North America Rheumatoid Arthritis Drug Revenue by Countries (2015-2020) (USD Million)
Table 69. North America Rheumatoid Arthritis Drug Revenue Market Share by Countries (2015-2020)
Table 70. Europe Rheumatoid Arthritis Drug Sales by Countries (2015-2020) (K Units)
Table 71. Europe Rheumatoid Arthritis Drug Sales Market Share by Countries (2015-2020)
Table 72. Europe Rheumatoid Arthritis Drug Revenue by Countries (2015-2020) (USD Million)
Table 73. Asia-Pacific Rheumatoid Arthritis Drug Sales by Regions (2015-2020) (K Units)
Table 74. Asia-Pacific Rheumatoid Arthritis Drug Sales Market Share by Regions (2015-2020)
Table 75. Asia-Pacific Rheumatoid Arthritis Drug Revenue by Regions (2015-2020) (USD Million)
Table 76. South America Rheumatoid Arthritis Drug Sales by Countries (2015-2020) (K Units)
Table 77. South America Rheumatoid Arthritis Drug Sales Market Share by Countries (2015-2020)
Table 78. South America Rheumatoid Arthritis Drug Revenue by Countries (2015-2020) (USD Million)
Table 79. South America Rheumatoid Arthritis Drug Revenue Market Share by Countries (2015-2020)
Table 80. Middle East & Africa Rheumatoid Arthritis Drug Sales by Countries (2015-2020) (K Units)
Table 81. Middle East & Africa Rheumatoid Arthritis Drug Sales Market Share by Countries (2015-2020)
Table 82. Middle East & Africa Rheumatoid Arthritis Drug Revenue by Countries (2015-2020) (USD Million)
Table 83. Middle East & Africa Rheumatoid Arthritis Drug Revenue Market Share by Countries (2015-2020)
Table 84. Global Rheumatoid Arthritis Drug Sales by Type (2015-2020) (K Units)
Table 85. Global Rheumatoid Arthritis Drug Sales Share by Type (2015-2020)
Table 86. Global Rheumatoid Arthritis Drug Revenue by Type (2015-2020) (USD Million)
Table 87. Global Rheumatoid Arthritis Drug Revenue Share by Type (2015-2020)
Table 88. Global Rheumatoid Arthritis Drug Sales by Application (2015-2020) (K Units)
Table 89. Global Rheumatoid Arthritis Drug Sales Share by Application (2015-2020)
Table 90. Global Rheumatoid Arthritis Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 91. Global Rheumatoid Arthritis Drug Market Share Forecast by Regions (2021-2025)
Table 92. Global Rheumatoid Arthritis Drug Sales Forecast by Type (2021-2025) (K Units)
Table 93. Global Rheumatoid Arthritis Drug Market Share Forecast by Type (2021-2025)
Table 94. Global Rheumatoid Arthritis Drug Sales Forecast by Application (2021-2025)
Table 95. Global Rheumatoid Arthritis Drug Market Share Forecast by Application (2021-2025)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Rheumatoid Arthritis Drug Picture
Figure 2. Global Sales Market Share of Rheumatoid Arthritis Drug by Type in 2019
Figure 3. Biopharmaceutical Picture
Figure 4. Pharmaceuticals Picture
Figure 5. Rheumatoid Arthritis Drug Sales Market Share by Application in 2018
Figure 6. Prescription Picture
Figure 7. Over-the-Counter (OTC) Picture
Figure 8. Global Rheumatoid Arthritis Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Rheumatoid Arthritis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Rheumatoid Arthritis Drug Sales Market Share by Manufacturer in 2019
Figure 29. Global Rheumatoid Arthritis Drug Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Rheumatoid Arthritis Drug Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Rheumatoid Arthritis Drug Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Rheumatoid Arthritis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Rheumatoid Arthritis Drug Revenue Market Share by Regions (2015-2020)
Figure 36. Global Rheumatoid Arthritis Drug Revenue Market Share by Regions in 2018
Figure 37. North America Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
Figure 38. Europe Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
Figure 40. South America Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020)
Figure 42. North America Rheumatoid Arthritis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Rheumatoid Arthritis Drug Sales Market Share by Countries (2015-2020)
Figure 44. North America Rheumatoid Arthritis Drug Sales Market Share by Countries in 2018
Figure 45. North America Rheumatoid Arthritis Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Rheumatoid Arthritis Drug Revenue Market Share by Countries in 2018
Figure 47. United States Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Rheumatoid Arthritis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Rheumatoid Arthritis Drug Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Rheumatoid Arthritis Drug Revenue Market Share by Countries in 2019
Figure 53. Germany Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Rheumatoid Arthritis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Rheumatoid Arthritis Drug Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Rheumatoid Arthritis Drug Revenue Market Share by Regions 2019
Figure 61. China Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Rheumatoid Arthritis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Rheumatoid Arthritis Drug Sales Market Share by Countries in 2019
Figure 68. South America Rheumatoid Arthritis Drug Revenue Market Share by Countries in 2019
Figure 69. Brazil Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Rheumatoid Arthritis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Rheumatoid Arthritis Drug Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Rheumatoid Arthritis Drug Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Rheumatoid Arthritis Drug Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Rheumatoid Arthritis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Rheumatoid Arthritis Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Rheumatoid Arthritis Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Rheumatoid Arthritis Drug Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Rheumatoid Arthritis Drug Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Rheumatoid Arthritis Drug Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Rheumatoid Arthritis Drug Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Rheumatoid Arthritis Drug Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
関節リウマチ治療の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…- 血清反応陽性用関節リウマチ治療薬の世界市場（～2026年） Arthritis means inflammation in a joint. The inflammation is characterized by swelling, pain, and redness within the joint. This type of arthritis is known to cause chronic inflammatory disorder in the hands and feet. The Americas dominated the overall market in terms of revenue in 2016 owing to the…
- 関節リウマチ診断検査の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The goals of rheumatoid arthritis treatment are to reduce pain, decrease inflammation and improve a person's overall functioning. Market Analysis and Insights: Global Rheumatoid Arthritis Diagnosis Tests Market Th…
- 関節リウマチ治療薬の世界市場（～2026年） Rheumatoid Arthritis Drugs include prescription and OTC. The increasing prevalence of arthritis, the increasing acceptance of biopharmaceuticals, and the development of clear regulatory guidelines are major trends that are expected to trigger market growth. Market Analysis and Insights: Global Rheum…
- 関節リウマチ診断検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Rheumatoid Arthritis Diagnostic Tests market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…